Effectiveness of First‐Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA

BACKGROUND. Scant real‐world data exist on the clinical outcomes associated with the use of bevacizumab‐containing chemotherapy (B+CT) in patients with metastatic colorectal cancer (mCRC). The primary objective of the GRETA cohort study was to compare the overall survival (OS) of patients with mCRC...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Franchi, Matteo, Barni, Sandro, Tagliabue, Giovanna, Ricci, Paolo, Mazzucco, Walter, Tumino, Rosario, Caputo, Antonietta, Corrao, Giovanni
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2018
Ämnen:
Health Outcomes and Economics of Cancer Care
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519764/
https://ncbi.nlm.nih.gov/pubmed/30097524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0314
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk